AgeX Therapeutics (AGE) executive Sternberg received 5,000 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Hal Sternberg (executive at AgeX Therapeutics Inc., AGE) reported that they received 5,000 shares on Jun 4, 2021.
- Reporting person
- Sternberg Hal
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 4, 2021 | Grant or award (A) | Option to Purchase Common StockOn 5,000 Common Stock1 | +5,000 | - | - | 5,000 direct |
Holdings before and after
- Option to Purchase Common Stock: 0 to 5,000 direct
Footnotes from the filing
- 1. Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Sternberg report in this AGE Form 4?
Hal Sternberg (executive at AgeX Therapeutics Inc., AGE) reported that they received 5,000 shares on Jun 4, 2021.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for AGE
Earlier insider filings at AGE
- Jun 8, 2021SEC Form 4 filed by Park Andrea Eun Jae
- Jun 8, 2021SEC Form 4 filed by WEST MICHAEL D
- Jun 8, 2021SEC Form 4 filed by MALIK NAFEES NASEER
- Mar 16, 2021SEC Form 4: D Michael West exercised 3,125 units of Common Stock at a strike of $0.00 and disposed of $2,607 worth of Common Stock (1,284 units at $2.03), increasing direct ownership by 6% to 32,439 units
- Feb 9, 2021SEC Form 4 filed by Ltd Juvenescence
Quantisnow market dataAMEX
AGE
AgeX Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for AGE
Full AGE profile on Quantisnow Follow AGE and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time